• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB Back to Search Results
Catalog Number 7D2648
Device Problems False Positive Result (1227); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
No kit lot number was provided for a specific investigation.No sample was returned for further testing, and no additional information was provided.A review of complaint trends revealed that all of the alere determine hiv ½ ag/ab combo lots are performing according to label claims.The exact root cause of the reported issue could not be determined.The available evidence suggests that the device is performing within labeled claims.
 
Event Description
A customer reported a false positive result with determine hiv 1/2 ag/ab combo.Sample information was not provided.Information further specifying the false positive result as antigen and/or antibody was not provided.Additional and/or confirmation testing was not provided.Attempts to gain further information were unsuccessful.Customer reported the patient was a double mastectomy cancer patient, and that the false positive result was expected, and not questioned.No further patient information, including pregnancy and art, was provided.There is insufficient information to determine if a malfunction occurred.Per the alere determine hiv-1/2 ag/ab combo product insert limitations: a reactive result using alere determine hiv-1/2 ag/ab combo suggests the presence of hiv-1 p24 antigen and/or antibodies to hiv-1 and/or hiv-2 in the sample.The reactive result is interpreted as preliminary positive for hiv-1 p24 antigen and/or antibodies to hiv-1 and/or hiv-2.Alere determine hiv-1/2 ag/ab combo is intended as aid in the diagnosis of infection with hiv-1/2.Specimens from individuals with toxoplasma igg, human anti-mouse antibodies, rheumatoid factor, elevated triglycerides (above 600 mg/dl), herpes simplex virus infection, hospitalized and cancer patients may give false positive test results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DETERMINE HIV-1/2 AG/AB COMBO
Type of Device
IVD FOR HIV 1/2 AG/AB
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer (Section G)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
alonna pitreau
10 southgate road
scarborough, ME 04074
2077305717
MDR Report Key10568561
MDR Text Key208158565
Report Number1221359-2020-00289
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP120037-0
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Catalogue Number7D2648
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/27/2020
Initial Date FDA Received09/22/2020
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-